The UK SACT (Systemic Anti-Cancer Therapy) Board provides guidance, oversight and support for the continuing development of SACT services in the UK.
The term systemic anti-cancer therapy (SACT) is now used to describe all types of drugs used to treat cancer. This includes chemotherapy, targeted therapies and immunotherapies, as well as other agents used to treat cancer.
Advising on the development and delivery of safe, high-quality SACT services.
Working collaboratively with other groups and organisations across the UK involved in the delivery of SACT services, including the Chemotherapy Clinical Reference Group and the Joint Collegiate Council for Oncology.
Coordinating work at a national level to support commissioning and delivery of SACT services locally.
The UK SACT Board has a forward work programme which includes the following: